ClinicalTrials.govpublic full text
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration
hereditary angioedema, hae, c1 inhibitor (c1inh), subcutaneous, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807578
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.